Tuberculosis: finding a new potential antimycobacterium derivative in a aldehyde-arylhydrazone-oxoquinoline series
Autor(a) principal: | |
---|---|
Data de Publicação: | 2012 |
Outros Autores: | , , , , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Institucional da FIOCRUZ (ARCA) |
Texto Completo: | https://www.arca.fiocruz.br/handle/icict/36485 |
Resumo: | 2020-10-16 |
id |
CRUZ_63c2a0729209fa715126614932394df1 |
---|---|
oai_identifier_str |
oai:www.arca.fiocruz.br:icict/36485 |
network_acronym_str |
CRUZ |
network_name_str |
Repositório Institucional da FIOCRUZ (ARCA) |
repository_id_str |
2135 |
spelling |
Santos, Fernanda da C.Castro, Helena C.Lourenço, Maria Cristina S.Abreu, Paula AlvarezBatalha, Pedro N.Cunha, Anna C.Carvalho, Guilherme S. L.Rodrigues, Carlos R.Medeiros, Cid A.Souza, Simone D.Ferreira, Vitor F.Souza, Maria C. B. V. de2019-10-16T13:16:59Z2019-10-16T13:16:59Z2012SANTOS, Fernanda da C. et al. Tuberculosis: finding a new potential antimycobacterium derivative in a aldehyde-arylhydrazone-oxoquinoline series. Current Microbiology, v. 65, p. 455-460, 2012.0343-8651https://www.arca.fiocruz.br/handle/icict/3648510.1007/s00284-012-0176-61432-0991engSpringerTuberculosis: finding a new potential antimycobacterium derivative in a aldehyde-arylhydrazone-oxoquinoline seriesinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/article2020-10-16Universidade Federal Fluminense. Departamento de Química Orgânica. Programa de Pós-Graduação em Química. Niterói, RJ, Brasil.Universidade Federal Fluminense. Departamento de e Biologia Celular e Molecular. Laboratório de Antibióticos, Bioquímica e Modelagem Molecular. Niterói, RJ, Brasil.Fundação Oswaldo Cruz. Instituto de Pesquisa Evandro Chagas. Rio de Janeiro, RJ, Brasil.Universidade Federal Fluminense. Departamento de e Biologia Celular e Molecular. Laboratório de Antibióticos, Bioquímica e Modelagem Molecular. Niterói, RJ, Brasil.Universidade Federal Fluminense. Departamento de Química Orgânica. Programa de Pós-Graduação em Química. Niterói, RJ, Brasil.Universidade Federal Fluminense. Departamento de Química Orgânica. Programa de Pós-Graduação em Química. Niterói, RJ, Brasil.Fundação Oswaldo Cruz. Instituto de Pesquisa Evandro Chagas. Rio de Janeiro, RJ, Brasil.Universidade Federal do Rio de Janeiro. Faculdade de Farmácia. Departamento de Medicamentos. Laboratório de Modelagem Molecular & QSAR. Rio de Janeiro, RJ, Brasil.Universidade Federal Fluminense. Departamento de e Biologia Celular e Molecular. Laboratório de Antibióticos, Bioquímica e Modelagem Molecular. Niterói, RJ, Brasil.Universidade Federal do Rio de Janeiro. Faculdade de Farmácia. Departamento de Medicamentos. Laboratório de Modelagem Molecular & QSAR. Rio de Janeiro, RJ, Brasil.Universidade Federal Fluminense. Departamento de Química Orgânica. Programa de Pós-Graduação em Química. Niterói, RJ, Brasil.Universidade Federal Fluminense. Departamento de Química Orgânica. Programa de Pós-Graduação em Química. Niterói, RJ, Brasil.Tuberculosis (TB) is a contagious disease caused by Mycobacterium tuberculosis, which remains a serious public health problem. The emergence of resistant bacterial strains has continuously increased and new treatment options are currently in need. In this work, we identified a new potential aldehyde–arylhydrazone–oxoquinoline derivative (4e) with interesting chemical structural features that may be important for designing new anti-TB agents. This 1-ethyl-N0 -[(1E)-(5-nitro-2-furyl)methylene]-4-oxo-1,4-dihydroquinoline-3-carbohydrazide (4e) presented an in vitro active profile against M. tuberculosis H37Rv strain (minimum inhibitory concentration, MIC = 6.25 lg/mL) better than other acylhydrazones described in the literature (MIC = 12.5 lg/mL) and close to other antitubercular agents currently on the market. The theoretical analysis showed the importance of several structural features that together with the 5-nitro-2-furyl group generated this active compound (4e). This new compound and the analysis of its molecular properties may be useful for designing new and more efficient antibacterial drugs.TuberculosisAntimycobacteriumAldehyde-arylhydrazone-oxoquinoline seriesinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da FIOCRUZ (ARCA)instname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZLICENSElicense.txttext/plain1748https://www.arca.fiocruz.br/bitstream/icict/36485/1/license.txt8a4605be74aa9ea9d79846c1fba20a33MD51ORIGINALve_Santos_Fernanda_etal_INI_2012.pdfve_Santos_Fernanda_etal_INI_2012.pdfapplication/pdf333185https://www.arca.fiocruz.br/bitstream/icict/36485/2/ve_Santos_Fernanda_etal_INI_2012.pdfd10642894aef76d351cb49c99ca7a47eMD52TEXTve_Santos_Fernanda_etal_INI_2012.pdf.txtve_Santos_Fernanda_etal_INI_2012.pdf.txtExtracted texttext/plain25541https://www.arca.fiocruz.br/bitstream/icict/36485/3/ve_Santos_Fernanda_etal_INI_2012.pdf.txt68c3d9f4ab50316af7d2b86b077c1e17MD53icict/364852022-11-29 15:02:36.196oai:www.arca.fiocruz.br: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Repositório InstitucionalPUBhttps://www.arca.fiocruz.br/oai/requestrepositorio.arca@fiocruz.bropendoar:21352022-11-29T18:02:36Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)false |
dc.title.pt_BR.fl_str_mv |
Tuberculosis: finding a new potential antimycobacterium derivative in a aldehyde-arylhydrazone-oxoquinoline series |
title |
Tuberculosis: finding a new potential antimycobacterium derivative in a aldehyde-arylhydrazone-oxoquinoline series |
spellingShingle |
Tuberculosis: finding a new potential antimycobacterium derivative in a aldehyde-arylhydrazone-oxoquinoline series Santos, Fernanda da C. Tuberculosis Antimycobacterium Aldehyde-arylhydrazone-oxoquinoline series |
title_short |
Tuberculosis: finding a new potential antimycobacterium derivative in a aldehyde-arylhydrazone-oxoquinoline series |
title_full |
Tuberculosis: finding a new potential antimycobacterium derivative in a aldehyde-arylhydrazone-oxoquinoline series |
title_fullStr |
Tuberculosis: finding a new potential antimycobacterium derivative in a aldehyde-arylhydrazone-oxoquinoline series |
title_full_unstemmed |
Tuberculosis: finding a new potential antimycobacterium derivative in a aldehyde-arylhydrazone-oxoquinoline series |
title_sort |
Tuberculosis: finding a new potential antimycobacterium derivative in a aldehyde-arylhydrazone-oxoquinoline series |
author |
Santos, Fernanda da C. |
author_facet |
Santos, Fernanda da C. Castro, Helena C. Lourenço, Maria Cristina S. Abreu, Paula Alvarez Batalha, Pedro N. Cunha, Anna C. Carvalho, Guilherme S. L. Rodrigues, Carlos R. Medeiros, Cid A. Souza, Simone D. Ferreira, Vitor F. Souza, Maria C. B. V. de |
author_role |
author |
author2 |
Castro, Helena C. Lourenço, Maria Cristina S. Abreu, Paula Alvarez Batalha, Pedro N. Cunha, Anna C. Carvalho, Guilherme S. L. Rodrigues, Carlos R. Medeiros, Cid A. Souza, Simone D. Ferreira, Vitor F. Souza, Maria C. B. V. de |
author2_role |
author author author author author author author author author author author |
dc.contributor.author.fl_str_mv |
Santos, Fernanda da C. Castro, Helena C. Lourenço, Maria Cristina S. Abreu, Paula Alvarez Batalha, Pedro N. Cunha, Anna C. Carvalho, Guilherme S. L. Rodrigues, Carlos R. Medeiros, Cid A. Souza, Simone D. Ferreira, Vitor F. Souza, Maria C. B. V. de |
dc.subject.en.pt_BR.fl_str_mv |
Tuberculosis Antimycobacterium Aldehyde-arylhydrazone-oxoquinoline series |
topic |
Tuberculosis Antimycobacterium Aldehyde-arylhydrazone-oxoquinoline series |
description |
2020-10-16 |
publishDate |
2012 |
dc.date.issued.fl_str_mv |
2012 |
dc.date.accessioned.fl_str_mv |
2019-10-16T13:16:59Z |
dc.date.available.fl_str_mv |
2019-10-16T13:16:59Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.citation.fl_str_mv |
SANTOS, Fernanda da C. et al. Tuberculosis: finding a new potential antimycobacterium derivative in a aldehyde-arylhydrazone-oxoquinoline series. Current Microbiology, v. 65, p. 455-460, 2012. |
dc.identifier.uri.fl_str_mv |
https://www.arca.fiocruz.br/handle/icict/36485 |
dc.identifier.issn.pt_BR.fl_str_mv |
0343-8651 |
dc.identifier.doi.none.fl_str_mv |
10.1007/s00284-012-0176-6 |
dc.identifier.eissn.none.fl_str_mv |
1432-0991 |
identifier_str_mv |
SANTOS, Fernanda da C. et al. Tuberculosis: finding a new potential antimycobacterium derivative in a aldehyde-arylhydrazone-oxoquinoline series. Current Microbiology, v. 65, p. 455-460, 2012. 0343-8651 10.1007/s00284-012-0176-6 1432-0991 |
url |
https://www.arca.fiocruz.br/handle/icict/36485 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.publisher.none.fl_str_mv |
Springer |
publisher.none.fl_str_mv |
Springer |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da FIOCRUZ (ARCA) instname:Fundação Oswaldo Cruz (FIOCRUZ) instacron:FIOCRUZ |
instname_str |
Fundação Oswaldo Cruz (FIOCRUZ) |
instacron_str |
FIOCRUZ |
institution |
FIOCRUZ |
reponame_str |
Repositório Institucional da FIOCRUZ (ARCA) |
collection |
Repositório Institucional da FIOCRUZ (ARCA) |
bitstream.url.fl_str_mv |
https://www.arca.fiocruz.br/bitstream/icict/36485/1/license.txt https://www.arca.fiocruz.br/bitstream/icict/36485/2/ve_Santos_Fernanda_etal_INI_2012.pdf https://www.arca.fiocruz.br/bitstream/icict/36485/3/ve_Santos_Fernanda_etal_INI_2012.pdf.txt |
bitstream.checksum.fl_str_mv |
8a4605be74aa9ea9d79846c1fba20a33 d10642894aef76d351cb49c99ca7a47e 68c3d9f4ab50316af7d2b86b077c1e17 |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 MD5 |
repository.name.fl_str_mv |
Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ) |
repository.mail.fl_str_mv |
repositorio.arca@fiocruz.br |
_version_ |
1798324953330745344 |